Literature DB >> 9657977

Critical role of arg433 in rat transketolase activity as probed by site-directed mutagenesis.

Y Soh1, B J Song, J Jeng, A T Kallarakal.   

Abstract

It has been shown that one arginine per monomer at an unknown position is essential for enzyme activity of the homodimeric transketolase (TK) [Kremer, Egan and Sable (1980) J. Biol. Chem. 255, 2405-2410]. To identify the critical arginine, four highly conserved arginine residues of rat TK (Arg102, Arg350, Arg433 and Arg506) were replaced with alanine by site-directed mutagenesis. Wild-type and mutant TK proteins were produced in Escherichia coli and characterized. The Arg102-->Ala mutant exhibited similar catalytic activity to the wild-type enzyme, whereas Arg350-->Ala, Arg506-->Ala and Arg433-->Ala mutants exhibited 36.7, 37.0 and 6.1% of the wild-type activity respectively. Three recombinant proteins (wild-type, Arg350-->Ala and Arg433-->Ala) were purified to apparent homogeneity using Ni2+-affinity chromatography and further characterized. All these proteins were able to form homodimers (148 kDa), as shown by immunoblot analysis subsequent to non-denaturing gel electrophoresis. The Arg433-->Ala mutant protein was less stable than the wild-type and Arg350-->Ala proteins at 55 degrees C. Kinetic analyses revealed that both Vmax and Km values were markedly affected in the Arg433-->Ala mutant. The Km values for two substrates xylulose 5-phosphate and ribose 5-phosphate were 11.5- and 24.3-fold higher respectively. The kcat/Km values of the Arg433-->Ala mutant for the two substrates were less than 1% of those of the wild-type protein. Molecular modelling of the rat TK revealed that Arg433 of one monomer has three potential hydrogen-bond interactions with the catalytically important highly conserved loop of the other monomer. Thus, our biochemical analyses and modelling data suggest the critical role of the previously uncharacterized Arg433 in TK activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9657977      PMCID: PMC1219594          DOI: 10.1042/bj3330367

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Three-dimensional structure of apotransketolase. Flexible loops at the active site enable cofactor binding.

Authors:  M Sundström; Y Lindqvist; G Schneider
Journal:  FEBS Lett       Date:  1992-11-30       Impact factor: 4.124

2.  Occurrence of transketolase abnormalities in extracts of foreskin fibroblasts from patients with Alzheimer's disease.

Authors:  F Paoletti; A Mocali; M Marchi; S Sorbi; S Piacentini
Journal:  Biochem Biophys Res Commun       Date:  1990-10-30       Impact factor: 3.575

3.  Accurate modeling of protein conformation by automatic segment matching.

Authors:  M Levitt
Journal:  J Mol Biol       Date:  1992-07-20       Impact factor: 5.469

4.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

5.  Reduced stability of rat brain transketolase after conversion to the apo form.

Authors:  M D Jeyasingham; O E Pratt; A D Thomson; G K Shaw
Journal:  J Neurochem       Date:  1986-07       Impact factor: 5.372

6.  Improved determination of transketolase activity in erythrocytes.

Authors:  T Takeuchi; K Nishino; Y Itokawa
Journal:  Clin Chem       Date:  1984-05       Impact factor: 8.327

7.  Nucleotide and predicted amino acid sequence of a cDNA clone encoding part of human transketolase.

Authors:  M Abedinia; R Layfield; S M Jones; P F Nixon; J S Mattick
Journal:  Biochem Biophys Res Commun       Date:  1992-03-31       Impact factor: 3.575

8.  DNA sequence of the yeast transketolase gene.

Authors:  T S Fletcher; I L Kwee; T Nakada; C Largman; B M Martin
Journal:  Biochemistry       Date:  1992-02-18       Impact factor: 3.162

9.  Studies of transketolase abnormality in Alzheimer's disease.

Authors:  K F Sheu; D D Clarke; Y T Kim; J P Blass; B J Harding; J DeCicco
Journal:  Arch Neurol       Date:  1988-08

10.  Three-dimensional structure of transketolase, a thiamine diphosphate dependent enzyme, at 2.5 A resolution.

Authors:  Y Lindqvist; G Schneider; U Ermler; M Sundström
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

View more
  3 in total

1.  High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats.

Authors:  R Babaei-Jadidi; N Karachalias; C Kupich; N Ahmed; P J Thornalley
Journal:  Diabetologia       Date:  2004-12-11       Impact factor: 10.122

2.  The crystal structure of human transketolase and new insights into its mode of action.

Authors:  Lars Mitschke; Christoph Parthier; Kathrin Schröder-Tittmann; Johannes Coy; Stefan Lüdtke; Kai Tittmann
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

3.  Rapid degradation of hypoxia-inducible factor-1alpha by KRH102053, a new activator of prolyl hydroxylase 2.

Authors:  H J Choi; B-J Song; Y-D Gong; W J Gwak; Y Soh
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.